TirzepatideInfo
Back to BlogEligibility

GLP-1 Telehealth Eligibility: Who Actually Qualifies

August 5, 2026·10 min read

Telehealth platforms vary enormously in how carefully they assess whether a GLP-1 is appropriate for you. Some publish exact BMI thresholds, required lab values and a list of disqualifying conditions. Others advertise the absence of gates as a feature. Understanding the standard clinical criteria lets you judge which kind of provider you are dealing with.

The standard clinical criteria

FDA-approved GLP-1s for chronic weight management are indicated for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidaemia or obstructive sleep apnea. Nearly every reputable provider works from that framework, and insurers require it for prior authorisation.

The most detailed published criteria we found

Amazon One Medical publishes ages 18-64, BMI 30+ or 27+ with a related condition, fasting glucose at or below 125 mg/dL, A1c at or below 6.4%, and not pregnant, nursing or trying to conceive within two months. It also names disqualifying conditions: medullary thyroid cancer history, MEN2, inflammatory bowel disease, gastroparesis, pancreatitis, gallbladder disease, heart failure, and kidney disease with eGFR under 60. That is the standard other providers should be measured against.

Absolute contraindications

  • Personal or family history of medullary thyroid carcinoma. GLP-1 receptor agonists carry a boxed warning based on thyroid C-cell tumours observed in rodents.
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
  • Known hypersensitivity to the active ingredient or any excipient.
  • Pregnancy. GLP-1s are not recommended in pregnancy, and providers generally require you not be trying to conceive within a defined window.

Conditions requiring careful clinical assessment

  • History of pancreatitis.
  • Gastroparesis or significant gastrointestinal motility disorders.
  • Gallbladder disease — rapid weight loss increases gallstone risk.
  • Diabetic retinopathy, where rapid glycaemic improvement can worsen the condition.
  • Significant renal impairment. Dehydration from GI side effects can precipitate acute kidney injury.
  • History of eating disorders, where appetite-suppressing medication requires particular care.
  • Concurrent insulin or sulfonylurea use, which raises hypoglycaemia risk.

How different providers actually assess you

ApproachWhat it looks likeExamples
Published criteria plus required labsExact BMI, age and lab thresholds published; labs required before prescribingAmazon One Medical, LevelsRx
Published criteria, labs at clinician discretionBMI thresholds and contraindications published; labs ordered where indicated24hrdoc, Circle Medical, AgelessRx
Live clinician visit, criteria not publishedReal video visit determines appropriateness, but criteria are not stated publiclyMidi Health, Rixa Health, Maven Clinic, Shapely
Asynchronous review, criteria not publishedQuestionnaire reviewed by a clinician without a live visitBelle Health, Fitish RX, Cora Health
Explicitly minimal gatingMarketed as having no BMI restrictionsBelle Health
"No BMI restrictions" is a business policy, not a clinical finding

Some platforms advertise the absence of a BMI gate as a benefit. It removes friction, but the standard criteria exist because GLP-1s carry real risks and the risk-benefit calculation changes at lower BMIs. A clinician still reviews the intake at these platforms and can decline. Treat the claim as neutral at best — and be wary of any service where approval appears automatic.

What lab work is actually useful

Most telehealth platforms do not require labs. That does not mean labs are not worth having — it means the provider has chosen not to require them. Baseline testing gives your clinician a reference point and can surface a contraindication before you start.

Kidney function (creatinine, eGFR)

Amazon requires this. GI side effects can cause dehydration and acute kidney injury, and significant renal impairment changes the risk calculation.

Fasting glucose or HbA1c

Distinguishes prediabetes and diabetes from simple obesity, which affects both drug choice and insurance coverage pathways.

Lipid panel

Establishes a cardiovascular baseline and helps document a weight-related comorbidity for prior authorisation.

Thyroid function

Not a screen for the boxed-warning contraindication, which is based on history rather than a blood test, but useful for identifying thyroid dysfunction contributing to weight change.

Where to get labs affordably

Shapely publishes a $75 flat rate at Labcorp for uninsured patients. If you have insurance, labs ordered by a conventional practice like Circle Medical or Indigo Health are usually billed through your plan at far less than telehealth cash-pay lab arrangements.

State rules that catch people out

  • Some states require at least one in-person visit before a provider can prescribe. Klarity Health discloses this explicitly; most platforms do not.
  • Compounded medication shipping is restricted in some states. Coby Health excludes AR, LA, MS and NM. Alloy excludes AL, AR, CA, NV, LA, MS and DC for compounded products.
  • Some providers serve only a handful of states — Shapely covers CA, FL, NY and TX; Levity publishes a 35-state list.
  • A few providers confirm nationwide coverage: Precision Telemed states all 50 states, and Klarity Health has providers in all 50.

What to ask before you pay

  1. What are your BMI and clinical eligibility criteria?
  2. Do you require lab work, and if so which tests and at what cost?
  3. Will I have a live consultation with a clinician, or is review asynchronous?
  4. Which conditions disqualify me from treatment?
  5. Do you serve my state, and does that differ for compounded versus brand-name medication?
  6. What happens if I am declined — is any fee refunded?

Frequently asked questions

Can I get a GLP-1 if my BMI is under 27?

FDA-approved indications for chronic weight management start at BMI 30, or 27 with a weight-related condition, so a BMI under 27 falls outside the approved use. Some platforms will still prescribe — Belle Health states it has no BMI restrictions — and AgelessRx publishes that a BMI of 24.9 or below is not eligible. Understand that prescribing below the approved threshold is a clinical judgement outside the labelled indication, and discuss the risk-benefit balance honestly with a clinician.

Will a telehealth provider tell me if I don't qualify?

The better ones will, and some make a point of it. Midi Health states plainly that not everyone is a candidate, Nexlife markets the fact that not everyone qualifies as a safety feature, and Amazon publishes an explicit list of disqualifying conditions. Providers where approval appears automatic warrant more scepticism, not less.

Do I need blood tests before starting a GLP-1?

Most telehealth providers do not require them; Amazon One Medical does, specifying creatinine, eGFR and fasting glucose or A1c. Even where not required, baseline kidney function, A1c and lipids are clinically useful and can identify a problem before you start. If you have any cardiac, renal or metabolic history, get them.

What disqualifies someone from GLP-1 treatment entirely?

A personal or family history of medullary thyroid carcinoma, MEN2 syndrome, known hypersensitivity to the drug, and pregnancy are the clearest absolute contraindications. Conditions requiring careful assessment include pancreatitis history, gastroparesis, gallbladder disease, significant renal impairment, diabetic retinopathy and eating disorder history.

Sources

  • Amazon One Medical published eligibility criteria and disqualifying conditions (accessed August 2026)
  • FDA-approved labelling for Wegovy, Zepbound and Saxenda, including boxed warning on thyroid C-cell tumours
  • Provider-published eligibility statements for 24hrdoc, AgelessRx, LevelsRx, Circle Medical, Klarity Health, Belle Health, Coby Health, Alloy and Shapely (accessed August 2026)
  • Google Search results collected via Bright Data SERP API, August 2026

Medical disclaimer: This article is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate for you. Do not start, change or stop any medication without consulting your healthcare provider.

Compare GLP-1 providers

We review every major online GLP-1 provider on real total cost, medication type, pharmacy disclosure and cancellation terms.